Maximum offer price is set at $52.10 per share.
Remegen is set to hold an initial public offering of 76.54m shares to the Hong Kong Stock Exchange, with an estimated worth of HK$3.71b.
The Hong Kong public offering is initially at 7.654m representing 10% of the total number of offer shares, whilst international offering is at 68.883m representing the remaining 90%.
The offer price is set at HK$52.10 per share, with minimum offers at $50.30
Trading will begin from November 9.
Do you know more about this story? Contact us anonymously through this link.